You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2025

CLINICAL TRIALS PROFILE FOR BENZYL BENZOATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BENZYL BENZOATE

Trial IDTitleStatusSponsorPhaseStart DateSummary
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT02927210 ↗ Injectable DMAU for Male Contraception in Healthy Male Volunteers (CCN015) Recruiting Los Angeles Biomedical Research Institute Phase 1 2016-12-01 This is a Phase I multicenter, double-blind, single dose, dose-ranging study, in healthy men to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of Dimethandrolone Undecanoate (DMAU) administered as an intramuscular or subcutaneous injection.
NCT00119483 ↗ Older Men and Testosterone Completed University Hospital of North Norway N/A 2005-09-01 Male hypogonadism is a clinical situation characterized by a low serum testosterone level in combination with a diversity of symptoms and signs such as reduced libido and vitality, decreased muscle mass, increased fat mass and depression. Similar symptoms in combination with subnormal testosterone levels are seen in some elderly men. Low testosterone levels are associated with known cardiovascular risk factors, and men with diabetes and stroke have lower testosterone levels than healthy men. Even though several publications have suggested that testosterone treatment in hypogonadal men may have beneficial effects, it is still uncertain if testosterone substitution in the aging man is indicated. Despite this uncertainty the sale of testosterone has increased enormously the last few years. We hypothesize that older men with subnormal testosterone levels have a varying degree of dysfunction/symptoms both physically and mentally, and that these dysfunction/symptoms can be improved with testosterone treatment.
>Trial ID>Title>Status>Phase>Start Date>Summary
Showing 1 to 3 of 3 entries

Clinical Trial Conditions for BENZYL BENZOATE

Condition Name

1110-0.100.10.20.30.40.50.60.70.80.911.1Healthy MenHouseholdsHypogonadism[disabled in preview]
Condition Name for BENZYL BENZOATE
Intervention Trials
Healthy Men 1
Households 1
Hypogonadism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

1110-0.100.10.20.30.40.50.60.70.80.911.1Pain, PostoperativeChronic PainAcute Pain[disabled in preview]
Condition MeSH for BENZYL BENZOATE
Intervention Trials
Pain, Postoperative 1
Chronic Pain 1
Acute Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BENZYL BENZOATE

Trials by Country

+
Trials by Country for BENZYL BENZOATE
Location Trials
United States 2
Norway 1
Taiwan 1
Gabon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State for BENZYL BENZOATE
Location Trials
Washington 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BENZYL BENZOATE

Clinical Trial Phase

33.3%33.3%33.3%0-0.100.10.20.30.40.50.60.70.80.911.1Phase 4Phase 2Phase 1[disabled in preview]
Clinical Trial Phase for BENZYL BENZOATE
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

50.0%25.0%25.0%0-0.200.20.40.60.811.21.41.61.822.2CompletedNot yet recruitingRecruiting[disabled in preview]
Clinical Trial Status for BENZYL BENZOATE
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BENZYL BENZOATE

Sponsor Name

trials000001111111Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterUniversity of WashingtonHealth Decisions[disabled in preview]
Sponsor Name for BENZYL BENZOATE
Sponsor Trials
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 1
University of Washington 1
Health Decisions 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

90.9%9.1%0-101234567891011OtherNIH[disabled in preview]
Sponsor Type for BENZYL BENZOATE
Sponsor Trials
Other 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Benzyl Benzoate: Clinical Trials Update, Market Analysis, and Future Projections

Benzyl benzoate, a versatile chemical compound, has been making waves in the pharmaceutical and personal care industries. This article delves into the latest clinical trials, market trends, and future projections for this multifaceted substance.

The Resurgence of Benzyl Benzoate in Scabies Treatment

In recent years, benzyl benzoate has experienced a revival in the treatment of scabies, a common skin condition caused by mites. This resurgence comes at a time when concerns about the efficacy of permethrin, the current standard treatment, are growing.

Clinical Trial Results: Benzyl Benzoate vs. Permethrin

A groundbreaking clinical trial conducted in Austria has shed new light on the effectiveness of benzyl benzoate compared to permethrin in treating scabies. The results are striking:

  • Benzyl benzoate 25% emulsion showed an 87% cure rate
  • Permethrin 5% cream only achieved a 26.9% cure rate[4]

These findings suggest that benzyl benzoate could be significantly more effective than permethrin in treating scabies infestations.

Tolerability and Safety Profile

While benzyl benzoate demonstrated superior efficacy, it's important to note its tolerability profile:

  • 47% of patients reported mild treatment-related adverse events with benzyl benzoate
  • Only 6% of patients reported mild itching with permethrin[7]

Despite the higher incidence of side effects, most were mild and short-lived, resolving without intervention.

Market Analysis: The Growing Demand for Benzyl Benzoate

The global benzyl benzoate market is experiencing steady growth, driven by its diverse applications in pharmaceuticals, personal care products, and other industries.

Market Size and Growth Projections

According to recent market research:

  • The global benzyl benzoate market was valued at USD 72.10 million in 2023
  • It is projected to reach USD 84.28 million by 2032
  • The market is expected to grow at a CAGR of 1.75% during this period[8]

Regional Market Dynamics

The Asia Pacific region dominates the global benzyl benzoate market, accounting for over 42% of total revenue in 2022. This dominance is attributed to:

  • Rapidly expanding textile, cosmetics, and pharmaceutical industries
  • China's leading position in the global textile and fragrance industries
  • India's growing pharmaceutical and healthcare sectors[3]

Factors Driving Market Growth

Several factors are contributing to the increasing demand for benzyl benzoate:

1. Pharmaceutical Applications

The pharmaceutical industry's growing demand for benzyl benzoate is a key driver of market growth. This is due to:

  • An aging population
  • Increasing prevalence of chronic diseases
  • Rising applications in drug formulations[3]

2. Personal Care and Cosmetics Industry

The personal care and cosmetics sector is another significant contributor to benzyl benzoate's market growth. Its use in fragrances and as a solvent in various products is driving demand.

3. Textile Industry

Benzyl benzoate's applications in the textile industry, particularly in China, are fueling market growth in the Asia Pacific region.

Emerging Trends in Benzyl Benzoate Production and Use

Shift Towards Sustainable Production

The benzyl benzoate industry is increasingly focusing on sustainable production methods. This trend is driven by:

  • Environmental concerns
  • Regulatory pressures
  • Consumer demand for eco-friendly products

Manufacturers are exploring organic synthesis of raw materials to produce safer and more efficient industrial grades of benzyl benzoate[2].

Innovation in Applications

Ongoing research is uncovering new applications for benzyl benzoate, expanding its potential market. These include:

  • Use as an insecticide to repel mosquitoes
  • Applications as a solvent for cellulose derivatives
  • Potential use as a plasticizer in various industries[3]

Challenges and Opportunities in the Benzyl Benzoate Market

Challenges

  1. Toxicity concerns: The raw materials used in benzyl benzoate production can be toxic, posing environmental and health risks.
  2. Regulatory hurdles: Stricter regulations on chemical production and use may impact the market.
  3. Competition from alternatives: The market faces competition from substitute products in various applications.

Opportunities

  1. Growing pharmaceutical demand: The increasing use of benzyl benzoate in drug formulations presents significant growth opportunities.
  2. Expansion in developing markets: Emerging economies offer untapped potential for market growth.
  3. Innovation in production methods: The development of greener, more efficient production processes could drive market expansion.

Future Outlook: Benzyl Benzoate in Scabies Treatment

The recent clinical trial results suggesting benzyl benzoate's superiority over permethrin in treating scabies could have significant implications for the future of scabies treatment.

"Considering the reduced sensitivity of scabies mites to 5% permethrin, our results suggest that benzyl benzoate is an appropriate first-line therapy in the treatment of scabies."[7]

This finding could lead to:

  • Revision of current treatment guidelines
  • Increased demand for benzyl benzoate in the pharmaceutical sector
  • Further research into optimizing benzyl benzoate formulations for scabies treatment

Key Takeaways

  1. Benzyl benzoate has shown superior efficacy to permethrin in treating scabies, potentially leading to changes in treatment guidelines.
  2. The global benzyl benzoate market is projected to grow steadily, reaching USD 84.28 million by 2032.
  3. Asia Pacific dominates the market, driven by its strong textile, cosmetics, and pharmaceutical industries.
  4. Sustainable production methods and new applications are emerging trends in the benzyl benzoate industry.
  5. The pharmaceutical sector, particularly in scabies treatment, presents significant growth opportunities for benzyl benzoate.

FAQs

  1. Q: What is benzyl benzoate primarily used for? A: Benzyl benzoate has various applications, including as a treatment for scabies, a fragrance ingredient in personal care products, and a solvent in the textile industry.

  2. Q: How effective is benzyl benzoate in treating scabies compared to permethrin? A: Recent clinical trials have shown benzyl benzoate 25% emulsion to be significantly more effective than permethrin 5% cream, with cure rates of 87% and 26.9% respectively.

  3. Q: What are the main factors driving growth in the benzyl benzoate market? A: Key growth drivers include increasing demand from the pharmaceutical and personal care industries, expanding applications in textiles, and growing markets in developing economies.

  4. Q: Are there any environmental concerns associated with benzyl benzoate production? A: Yes, traditional production methods use toxic raw materials. However, the industry is moving towards more sustainable, organic synthesis methods to address these concerns.

  5. Q: Which region dominates the global benzyl benzoate market? A: The Asia Pacific region dominates the market, accounting for over 42% of total revenue in 2022, primarily due to its strong textile, cosmetics, and pharmaceutical industries.

Sources cited: [2] https://www.businesswire.com/news/home/20200526005169/en/COVID-19-Outlook-and-Impact--Global-Benzyl-Benzoate-Market-2020-2024-Rising-Demand-for-Cosmetics-and-Personal-Care-Products-to-Boost-Market-Growth-Technavio [3] https://www.giiresearch.com/report/act1244163-benzyl-benzoate-market-growth-future-prospects.html [4] https://onlinelibrary.wiley.com/doi/full/10.1002/jvc2.289 [7] https://www.dermatologyadvisor.com/news/benzyl-benzoate-superior-to-permethrin-in-treating-scabies/ [8] https://www.credenceresearch.com/report/benzyl-benzoate-market

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.